DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – By August 3, Congo’s outbreak had escalated to 3,874 confirmed cases and 1,751 deaths, marking the nation’s largest recorded Ebola epidemic. It ranks second globally after the 2014 to 2016 West Africa outbreak. The nation reached over 1,000 confirmed cases within 40 days of initiating its response, a stark contrast to the approximately 235 days it took during the 2018 outbreak to hit the same number. This rapid increase highlights issues like delayed detection, weak surveillance systems, ongoing conflict, population mobility, and the lack of approved strain-specific medical countermeasures.
Congo’s Ministry of Public Health declared the outbreak on May 15 following tests that identified Bundibugyo virus in Ituri province. The WHO had first received a warning on May 5 after reports emerged of a deadly, unexplained illness near Mongbwalu. Investigations later revealed the virus had been circulating for months before detection. Initial tests in Bunia failed to identify Bundibugyo, as early symptoms were similar to malaria and other common febrile illnesses. This delay allowed infected individuals and their contacts to move freely through communities before health authorities could implement isolation and contact tracing measures.
The identification of Bundibugyo virus also affected response strategies. Unlike Zaire ebolavirus, for which licensed vaccines and antibody treatments are available, there are no approved vaccines or specific treatments for Bundibugyo virus disease. Consequently, patient care relies heavily on early diagnosis, isolation, supportive treatment, infection prevention, contact tracing, and safe burial practices. Although WHO has added a Bundibugyo diagnostic test to its emergency list and initiated treatment trials, these steps came after widespread transmission had already occurred.
Delayed detection hampers contact tracing efforts
The outbreak has expanded from Mongbwalu to 49 health zones across Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo. Ituri bears the majority of infections and fatalities, with Bunia, Rwampara, and Mongbwalu among the most severely affected. WHO tracked 17,863 contacts by July 30, but only around 75% received active follow-up in several affected regions. Authorities also report that many new cases are identified outside known contact chains, as surveillance teams often discover patients only after further exposure has taken place.
Ongoing conflict and displacement hinder surveillance efforts. Armed attacks have restricted access, disrupted response activities, and caused some health teams to halt operations. Movement along mining routes, trade corridors, crowded displacement camps, and cross-border crossings keeps large populations in motion within affected zones. Healthcare facilities face shortages of PPE, laboratory services, transportation, and trained personnel. As of July 30, Congo reported 151 infections and 44 deaths among health workers. Frontline workers have also ceased work in certain locations due to delayed or insufficient compensation.
Conflict, limited treatments, and systemic challenges impede containment
Ebola transmission occurs through direct contact with the blood or bodily fluids of infected or deceased individuals. It does not spread through casual proximity like influenza. Increased transmission is common in clinics lacking proper infection control and during burials involving contact with infected bodies. Over 60% of recent fatalities happened outside designated treatment centers, complicating safe burials and contact investigations. In response, Congo, WHO, and Africa CDC have expanded laboratory capacity, treatment facilities, community engagement, and border surveillance. Nonetheless, these efforts are still struggling to match the scale and speed of new cases.
Uganda declared the linked outbreak over on July 28 after 42 days without a new locally transmitted case. The single case treated in France did not lead to secondary infections, and the patient recovered. Meanwhile, Congo remains the epicenter of ongoing transmission, with a confirmed case fatality rate around 45% as of early August. The outbreak is accelerating due to delayed detection, incomplete contact tracing, and insecurity limiting access. The absence of approved vaccines and treatments for Bundibugyo virus further hampers containment efforts, unlike earlier Zaire Ebola epidemics. These combined factors explain the unusually rapid spread of cases.